Black men choose aggressive prostate cancer treatment—regardless of anticipated life expectancy—more often than Hispanic or ...

We transformed care for advanced prostate cancer, by validating inhibitors of androgen production as an effective cancer ...

Addressing systemic barriers and ensuring access to care are crucial for promoting treatment equity across diverse patient populations. Policy changes, increased funding, and culturally competent care ...

TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Read full article: Understanding breast cancer screenings: When to start, symptoms to watch for, and the role of advanced mammography Dr. Scot Ackerman. Read full article: JAXBest 2025: In the mood ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

"Prostate cancer is a worldwide problem. It is the most common cancer in men, with clear racial disparities,” said researcher Hui Li, PhD, of the University of Virginia School of Medicine’s Department ...

When facing a prostate cancer diagnosis, choosing the right treatment isn’t just about clinical outcomes — it’s also about personal priorities, which may include your quality of life, ability to work, ...

Prostate cancer has become a significant health concern among men, being the second leading cause of death in the United States. While the survival rate in men remains high, those who have advanced, ...

Medical practitioners are constantly updating and refining approaches to prostate cancer care, while new cutting-edge therapies are on the horizon ...